Form 4: HCW Biologics Director Gary M. Winer Reports Transaction in Company Stock
SEC Form 4
Director Gary M. Winer reports acquisition and disposal of HCW Biologics Inc. common stock and warrants related to a secured notes conversion.
Summary
- Gary M. Winer, a director of HCW Biologics Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 7, 2025, Winer acquired 2,308 shares of common stock at $26 per share and 1,154 common stock purchase warrants with an exercise price of $26.
- These acquisitions are related to a conversion agreement entered into on May 1, 2025, where $6.6 million of secured notes were converted into 253,083 shares and 126,540 warrants.
- Winer also disposed of 2,733 shares of common stock.
- Following these transactions, Winer directly owns 1,154 derivative securities and 2,733 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The conversion of secured notes into common stock and warrants may dilute existing shareholders' equity.
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/01/2025 | Date of the definitive conversion agreement. |
| 05/07/2025 | Date of the transaction (acquisition and disposal of securities). |
| 05/07/2030 | Expiration date of the common stock purchase warrants. |
| 05/08/2025 | Date of common stock transaction. |
| 05/09/2025 | Date of signature on the Form 4. |
Keywords
Form 4, HCW Biologics, Beneficial Ownership, Gary M. Winer, Stock Transaction, Secured Notes, Warrants, Conversion Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.